Literature DB >> 3385407

Partial nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue virus type 2, New Guinea C and PUO-218 strains.

A Gruenberg1, W S Woo, A Biedrzycka, P J Wright.   

Abstract

The nucleotide sequence and the deduced amino acid sequence for the genes encoding the structural proteins of two strains of dengue virus type 2 (DEN-2) were determined from cDNA clones. The genes for C, prM(M) and E proteins were sequenced for the prototype DEN-2 virus, the New Guinea C strain. Also sequenced were the prM(M) and E genes of PUO-218. This strain of DEN-2 was isolated during 1980 in Bangkok and had received a limited number of laboratory passages. Comparisons of the newly determined sequences with those published for the Jamaica 1409 and Puerto Rico PR-159 (S1 vaccine candidate) strains revealed a close relationship between New Guinea C virus and both the Jamaica and PUO-218 viruses (greater than 96% similarity in nucleotides of the E gene), whereas S1 virus was the most divergent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385407     DOI: 10.1099/0022-1317-69-6-1391

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins.

Authors:  B Falgout; M Pethel; Y M Zhang; C J Lai
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses.

Authors:  E Wang; H Ni; R Xu; A D Barrett; S J Watowich; D J Gubler; S C Weaver
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Processing of dengue virus type 2 structural proteins containing deletions in hydrophobic domains.

Authors:  A Gruenberg; P J Wright
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Expression of the NS1 gene of dengue virus type 2 using vaccinia virus. Dimerisation of the NS1 glycoprotein.

Authors:  C R Parrish; W S Woo; P J Wright
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.

Authors:  F Guirakhoo; R Weltzin; T J Chambers; Z X Zhang; K Soike; M Ratterree; J Arroyo; K Georgakopoulos; J Catalan; T P Monath
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3.

Authors:  F Preugschat; C W Yao; J H Strauss
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409).

Authors:  J G Aaskov; H M Geysen; T J Mason
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.

Authors:  C W Mandl; F Guirakhoo; H Holzmann; F X Heinz; C Kunz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

9.  Variation of the nucleotide and encoded amino acid sequences of the envelope gene from eight dengue-2 viruses.

Authors:  J Blok; S Samuel; A J Gibbs; U T Vitarana
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.

Authors:  Eva Lee; Roy A Hall; Mario Lobigs
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.